Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor-Reference-Cited by-同舟云学术

Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor

Published:2009-01 Issue:1 Volume:15 Page:210-216
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

ALEEM A.,SAIDU A.,ABDULKARIM H.,AL-DIAB A. R.,AL-SAGHEER A.,QAYUM A.,AL-MOMEN A. K.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2008.01865.x/fullpdf

Reference33 articles.

1. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs;Ehrenforth;Lancet,1992

2. UK Haemophilia Centre Doctors’ Organisation. The incidence of factor VIII and factor IX inhibitors in the haemophilia population of the UK and their effect on subsequent mortality, 1977-99;Darby;J Thromb Haemost,2004

3. Factor VIII inhibitors in mild and moderate severity haemophilia A. UK Haemophilia Centre Directors Organisation;Hay;J Thromb Haemost,1998

4. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors;Unuvar;Haemophilia,2000

5. Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany;Auerswald;Haemophilia,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia;Clinical and Applied Thrombosis/Hemostasis;2020-01-01

2. The Use of Rituximab with Immune Tolerance Induction Therapy for Hemophilia A with Inhibitors;Clinical Pediatric Hematology-Oncology;2015-04-30

3. Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review;European Journal of Haematology;2014-06-24

4. B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study;Molecular Therapy - Methods & Clinical Development;2014

5. The History and Evolution of the Clinical Effectiveness of Haemophilia Type A Treatment: A Systematic Review;Indian Journal of Hematology and Blood Transfusion;2012-11-04